📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Anabolic treatment for osteoporosis: teriparatide. (2017)

First Author: Eastell R

Attributed to: Centre for Integrated research into Musculoskeletal Ageing (CIMA) Renewal funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.11138/ccmbm/2017.14.1.173

PubMed Identifier: 29263728

Publication URI: http://europepmc.org/abstract/MED/29263728

Type: Journal Article/Review

Volume: 14

Parent Publication: Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases

Issue: 2

ISSN: 1724-8914